These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6380499)

  • 21. Intramolecularly quenched fluorogenic peptide substrates for human renin.
    Oliveira MC; Hirata IY; Chagas JR; Boschcov P; Gomes RA; Figueiredo AF; Juliano L
    Anal Biochem; 1992 May; 203(1):39-46. PubMed ID: 1524216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tetradecapeptide renin substrate on blood pressure, plasma renin activity, and vasopressin and adrenocorticotropin concentrations.
    Ramsay DJ; Brown C; Reid IA; Keil LC
    Endocrinology; 1979 Dec; 105(6):1406-9. PubMed ID: 227662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide inhibitors of renin in cardiovascular studies.
    Haber E
    Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renin system inhibitors at the level of the renin-substrate reaction].
    Corvol P; Michel JB; Evin G; Gardes J; Castro B; Menard J
    Ann Endocrinol (Paris); 1983; 44(5):339-42. PubMed ID: 6372641
    [No Abstract]   [Full Text] [Related]  

  • 25. No evidence for product inhibition of the renin-angiotensinogen reaction in the rat.
    Hackenthal E; Hackenthal R; Hofbauer KG
    Circ Res; 1977 Oct; 41(4 Suppl 2):49-54. PubMed ID: 902373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified peptides which display potent and specific inhibition of human renin.
    Luly JR; Plattner JJ; Stein H; Yi N; Soderquist J; Marcotte PA; Kleinert HD; Perun TJ
    Biochem Biophys Res Commun; 1987 Feb; 143(1):44-51. PubMed ID: 3548726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competitive inhibitors of renin. A review.
    Poulsen K; Burton J; Haber E
    Prog Biochem Pharmacol; 1976; 12():135-41. PubMed ID: 14338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New inhibitors of renin that contain novel phosphostatine Leu-Val replacements.
    Dellaria JF; Maki RG; Stein HH; Cohen J; Whittern D; Marsh K; Hoffman DJ; Plattner JJ; Perun TJ
    J Med Chem; 1990 Feb; 33(2):534-42. PubMed ID: 2105396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human renin: a new class of inhibitors.
    Dann JG; Stammers DK; Harris CJ; Arrowsmith RJ; Davies DE; Hardy GW; Morton JA
    Biochem Biophys Res Commun; 1986 Jan; 134(1):71-7. PubMed ID: 3511903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A redox switch in angiotensinogen modulates angiotensin release.
    Zhou A; Carrell RW; Murphy MP; Wei Z; Yan Y; Stanley PL; Stein PE; Broughton Pipkin F; Read RJ
    Nature; 2010 Nov; 468(7320):108-11. PubMed ID: 20927107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is angiotensinogen a renin inhibitor and not the substrate for renin?
    Poulsen K; Jacobsen J
    J Hypertens; 1986 Feb; 4(1):65-9. PubMed ID: 3514748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel renin inhibitors containing the amino acid statine.
    Boger J; Lohr NS; Ulm EH; Poe M; Blaine EH; Fanelli GM; Lin TY; Payne LS; Schorn TW; LaMont BI; Vassil TC; Stabilito II; Veber DF; Rich DH; Bopari AS
    Nature; 1983 May 5-11; 303(5912):81-4. PubMed ID: 6341856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does?
    Haber E
    J Hypertens; 1984 Jun; 2(3):223-30. PubMed ID: 6099385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence against inhibition of the renin-angiotensinogen reaction by des-angiotensin substrate in the rat.
    Hackenthal E; Hackenthal R; Hofbauer KG
    Clin Sci Mol Med Suppl; 1976 Dec; 3():155s-157s. PubMed ID: 1071595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. alpha,alpha-Difluoro-beta-aminodeoxystatine-containing renin inhibitory peptides.
    Thaisrivongs S; Schostarez HJ; Pals DT; Turner SR
    J Med Chem; 1987 Oct; 30(10):1837-42. PubMed ID: 3309315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin inhibitors. Design of angiotensinogen transition-state analogues containing novel. (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid.
    Thaisrivongs S; Pals DT; Kroll LT; Turner SR; Han FS
    J Med Chem; 1987 Jun; 30(6):976-82. PubMed ID: 3295239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of the dipsogenic action of tetradecapeptide renin substrate in dogs.
    Ramsay DJ; Reid IA; Brown C
    Endocrinology; 1979 Oct; 105(4):947-51. PubMed ID: 477607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent new inhibitors of human renin.
    Szelke M; Leckie B; Hallett A; Jones DM; Sueiras J; Atrash B; Lever AF
    Nature; 1982 Oct; 299(5883):555-7. PubMed ID: 6750410
    [No Abstract]   [Full Text] [Related]  

  • 39. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
    Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
    J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.